Outcome | N | Short-term mortality | Pvalue* | AUC | 95% CI | Pvalue** | |
---|---|---|---|---|---|---|---|
 |  | Yes | No |  |  |  |  |
DeCOPD score mean (sd) | 2484 | 9.03 (4.27) | 3.07 (3.4) | ≤0.0001 | 0.85 | 0.79 to 0.90 | Refa |
DeCOPD score (categorical) | 2484 |  |  | ≤0.0001 | 0.84 | 0.79 to 0.89 | 0.38 |
Risk | Â | Â | Â | Â | Â | Â | Â |
Mild | 1081 | 3 (0.28) | 1078 (99.72) | Â | Â | Â | Â |
Moderate | 865 | 11 (1.27) | 854 (98.73) | Â | Â | Â | Â |
Severe | 441 | 20 (4.54) | 421 (95.46) | Â | Â | Â | Â |
Very severe | 97 | 24 (24.74) | 73 (75.26) | Â | Â | Â | Â |
GOLD FEV1% | 2069 | Â | Â | 0.0133 | 0.62 | 0.56 to 0.69 | <0.0001 |
FEV1% ≥80 | 76 | 0 (0.0) | 76 (100) |  |  |  |  |
50 ≤ FEV1% <80 | 643 | 6 (0.93) | 637 (99.07) |  |  |  |  |
30 ≤ FEV1% <50 | 959 | 28 (2.92) | 931 (97.08) |  |  |  |  |
FEV1% ≤30 | 391 | 13 (3.32) | 378 (96.68) |  |  |  |  |
GOLD COPD combined assessment | 2090 | Â | Â | <0.002 | 0.71 | 0.67 to 0.75 | <0.0001 |
Low risk, low symptom burden | 286 | 1 (0.35) | 285 (99.65) | Â | Â | Â | Â |
Low risk, higher symptom burden | 335 | 4 (1.19) | 331 (98.81) | Â | Â | Â | Â |
High risk, low symptom burden | 351 | 0 (0.00) | 351 (100) | Â | Â | Â | Â |
High risk, higher symptom burden | 1118 | 46 (4.11) | 1072 (95.89) | Â | Â | Â | Â |
HADO score | 1887 | Â | Â | 0.0002 | 0.68 | 0.63 to 0.72 | <0.0001 |
Mild (<4) | 188 | 0 | 188 (100) | Â | Â | Â | Â |
Moderate (5 to 7) | 604 | 3 (0.50) | 601 (99.50) | Â | Â | Â | Â |
Severe (>8) | 1095 | 33 (3.01) | 1062 (96.99) | Â | Â | Â | Â |
ADO index (0 to 14) mean (sd) | 2067 | 11.36 (1.71) | 9.29 (2.19) | ≤0.0001 | 0.78 | 0.71 to 0.84 | 0.05 |